World Health Organization: For the first time, two vaccines specifically designed against Ebola Bundibugyo virus have now entered phase one safety trials in humans. In addition, two new animal studies of the vaccine against Zaire ebolavirus – the more common species – have shown promising evidence of cross protection in animals.

Home

China

World

Politics

Business

Sci-Tech

Health

Opinions

Video

Live

Radio

World Asia-Pacific Middle East Europe Americas Africa

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

Search Trends